Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × Toremifene × Clear all

NCT00003865 2017-07-13

Toremifene in Treating Patients With Ovarian Cancer

Phase 2 Withdrawn

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms